Drug Shortage Report for INCRUSE ELLIPTA
| Report ID | 101563 |
| Drug Identification Number | 02423596 |
| Brand name | INCRUSE ELLIPTA |
| Common or Proper name | umeclidinium (as bromide) dry powder for oral inhalation |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | UMECLIDINIUM |
| Strength(s) | 62.5MCG |
| Dosage form(s) | POWDER |
| Route of administration | INHALATION |
| Packaging size | 7's |
| ATC code | R03BB |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-12-10 |
| Estimated end date | 2020-02-15 |
| Actual end date | 2020-02-05 |
| Shortage status | Resolved |
| Updated date | 2020-02-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-02-06 | English | Compare |
| v4 | 2020-02-05 | French | Compare |
| v3 | 2020-02-05 | English | Compare |
| v2 | 2019-12-18 | French | Compare |
| v1 | 2019-12-18 | English | Compare |
Showing 1 to 5 of 5